However, there was no significant association between miR-124 expression and other clinicopathological factors, including age (P = 0.19), and tumor size (P = 0.13), ER status(P = 0.31), PR status(P = 0.15), and HER2 status(P = 0.08). This evidence concerns the gene ERBB2 and neoplasm.